BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2649867)

  • 1. A multicenter therapeutic study of 1100 children with brucellosis.
    Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
    Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.
    Roushan MR; Amiri MJ; Janmohammadi N; Hadad MS; Javanian M; Baiani M; Bijani A
    J Antimicrob Chemother; 2010 May; 65(5):1028-35. PubMed ID: 20215128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
    Hasanjani Roushan MR; Mohraz M; Hajiahmadi M; Ramzani A; Valayati AA
    Clin Infect Dis; 2006 Apr; 42(8):1075-80. PubMed ID: 16575723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood brucellosis: a study of 102 cases.
    al-Eissa YA; Kambal AM; al-Nasser MN; al-Habib SA; al-Fawaz IM; al-Zamil FA
    Pediatr Infect Dis J; 1990 Feb; 9(2):74-9. PubMed ID: 2314956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of human brucellosis.
    Solera J
    J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
    Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
    Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis.
    Roushan MR; Mohraz M; Janmohammadi N; Hajiahmadi M
    Pediatr Infect Dis J; 2006 Jun; 25(6):544-5. PubMed ID: 16732154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brucellosis: study of 222 cases. V. Treatment].
    Rivero-Puente A; Maravi-Poma E; García-Carasusan M; Lina-Cisoro L; Celador A; Uribarrena R; Borda F
    Rev Clin Esp; 1982 Aug 15-31; 166(3-4):111-4. PubMed ID: 7146530
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
    Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
    Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
    Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
    Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different combination therapies in the treatment of human brucellosis.
    Ersoy Y; Sonmez E; Tevfik MR; But AD
    Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.
    Solera J; Geijo P; Largo J; Rodriguez-Zapata M; Gijón J; Martinez-Alfaro E; Navarro E; Macia MA;
    Clin Infect Dis; 2004 Dec; 39(12):1776-82. PubMed ID: 15578399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on brucellosis: therapeutic challenges.
    Solera J
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S18-20. PubMed ID: 20692127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic effects of trimethoprim-sulfamethoxazole in children with biliary atresia: a new dosing regimen.
    Lares-Asseff I; Villegas F; Pérez G; Toledo A; Camacho A; López DC
    Arch Med Res; 1996; 27(2):183-90. PubMed ID: 8696062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
    Karabay O; Sencan I; Kayas D; Sahin I
    BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic treatment of brucellosis].
    Bertrand A
    Presse Med; 1994 Jun; 23(24):1128-31. PubMed ID: 7971834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
    Keramat F; Ranjbar M; Mamani M; Hashemi SH; Zeraati F
    Trop Doct; 2009 Oct; 39(4):207-10. PubMed ID: 19762571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for human brucellosis.
    Al-Tawfiq JA
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):109-20. PubMed ID: 18251668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.